Clinical Outcomes and Prognostic Factors of Salvage Treatment for Local Lymph Node Recurrence After Radical Resection of Oesophageal Carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616–1623. doi:10.1002/cncr.1122812655517
   PubMed Web of Science ®Google Scholar
• Natsugoe S, Matsumoto M, Okumura H, et al. Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer. Langenbecks Arch Surg. 2010;395:341–346. doi:10.1007/s00423-010-0592-720361205
   PubMed Web of Science ®Google Scholar
• Hsu PK, Wang BY, Huang CS, Wu YC, Hsu WH. Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection. J Gastrointest Surg. 2011;15:558–565. doi:10.1007/s11605-011-1458-121327531
   PubMed Web of Science ®Google Scholar
• Oppedijk V, van der Gaast A, van Lanschot JJ, et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014;32:385–391. doi:10.1200/JCO.2013.51.218624419108
   PubMed Web of Science ®Google Scholar
• Liu J, Cai X, Liu Q, Li H, Cheng Y, Fu X. Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer. Thorac Cancer. 2017;8:630–633.28941320
   PubMed Web of Science ®Google Scholar
• Ni W, Yang J, Deng W, et al. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma. BMC Cancer. 2020;20:144. doi:10.1186/s12885-020-6622-032087687
   PubMed Web of Science ®Google Scholar
• Nakamura T, Ota M, Narumiya K, et al. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol. 2008;15:2451–2457. doi:10.1245/s10434-008-0016-x18592318
   PubMed Web of Science ®Google Scholar
• Depypere L, Lerut T, Moons J, et al. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road. Dis Esophagus. 2017;30:1–8.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Mine S, Yamada K, et al. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg. 2014;62:685–692. doi:10.1007/s11748-014-0444-424965711
   PubMedGoogle Scholar
• Ma X, Zhao K, Guo W, et al. Salvage lymphadenectomy versus salvage radiotherapy/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma. Ann Surg Oncol. 2015;22:624–629. doi:10.1245/s10434-014-4008-825155397
   PubMed Web of Science ®Google Scholar
• Schizas D, Lazaridis II, Moris D, et al. The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature. World J Surg Oncol. 2018;16:55. doi:10.1186/s12957-018-1357-y29540179
   PubMed Web of Science ®Google Scholar
• Fakhrian K, Gamisch N, Schuster T, Thamm R, Molls M, Geinitz H. Salvage radiotherapy in patients with recurrent esophageal carcinoma. Strahlenther Onkol. 2012;188:136–142. doi:10.1007/s00066-011-0023-x22218502
   PubMed Web of Science ®Google Scholar
• Yamashita H, Jingu K, Niibe Y, et al. Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients. Radiat Oncol. 2017;12:38. doi:10.1186/s13014-017-0780-528219406
   PubMed Web of Science ®Google Scholar
• Kawamoto T, Nihei K, Sasai K, Karasawa K. Clinical outcomes and prognostic factors of chemoradiotherapy for postoperative lymph node recurrence of esophageal cancer. Jpn J Clin Oncol. 2018;48:259–264. doi:10.1093/jjco/hyx17129190352
   PubMed Web of Science ®Google Scholar
• Zhou YQ, Ding NX, Wang LJ, Liu W, Jiang M, Lu JC. Salvage radiochemotherapy for lymph node recurrence after radical surgery of esophageal cancer. Medicine (Baltimore). 2018;97:e9777. doi:10.1097/MD.000000000000977729384871
   PubMed Web of Science ®Google Scholar
• Chen J, Yin W, Yao H, Gu W. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma. Radiat Oncol. 2019;14:169. doi:10.1186/s13014-019-1377-y31533757
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247. doi:10.1016/j.ejca.2008.10.02619097774
   PubMed Web of Science ®Google Scholar
• Ninomiya I, Okamoto K, Fushida S, et al. Survival benefit of multimodal local therapy for repeat recurrence of thoracic esophageal squamous cell carcinoma after esophagectomy. Esophagus. 2019;16:107–113. doi:10.1007/s10388-018-0638-430155745
   PubMed Web of Science ®Google Scholar
• Bao Y, Liu S, Zhou Q, et al. Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern. Radiat Oncol. 2013;8:241. doi:10.1186/1748-717X-8-24124139225
   PubMed Web of Science ®Google Scholar
• Kobayashi R, Yamashita H, Okuma K, Shiraishi K, Ohtomo K, Nakagawa K. Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer. Dis Esophagus. 2014;27:72–78. doi:10.1111/dote.1206823551708
   PubMed Web of Science ®Google Scholar
• Ma DY, Tan BX, Liu M, Li XF, Zhou YQ, Lu Y. Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a Phase 2 single-institution study. Radiat Oncol. 2014;9:28. doi:10.1186/1748-717X-9-2824438695
   PubMed Web of Science ®Google Scholar
• Shi Y, Ge X, Gao Z, Liu S, Sun X, Luo J. Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinoma. Oncol Lett. 2019;18:2388–2393.31452733
   PubMed Web of Science ®Google Scholar
• Zhang J, Peng F, Li N, et al. Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer. Radiat Oncol. 2012;7:93. doi:10.1186/1748-717X-7-9322713587
   PubMed Web of Science ®Google Scholar
• Jingu K, Matsushita H, Takeda K, et al. Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a Phase II study. BMC Cancer. 2012;12:542. doi:10.1186/1471-2407-12-54223171077
   PubMed Web of Science ®Google Scholar
• Kim DE, Kim UJ, Choi WY, et al. Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapy. Cancer Res Treat. 2013;45:276–284. doi:10.4143/crt.2013.45.4.27624454000
   PubMed Web of Science ®Google Scholar
• Wu SX, Li XY, Xu HY, et al. Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer. Sci Rep. 2017;7:16870. doi:10.1038/s41598-017-17254-929203855
   PubMed Web of Science ®Google Scholar
• Chen H, Zhou L, Yang Y, Yang L, Chen L. Clinical effect of radiotherapy combined with chemotherapy for non-surgical treatment of the esophageal squamous cell carcinoma. Med Sci Monit. 2018;24:4183–4191. doi:10.12659/MSM.91032629915168
   PubMed Web of Science ®Google Scholar
• Chen M, Shen M, Lin Y, et al. Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Radiat Oncol. 2018;13:150. doi:10.1186/s13014-018-1086-y30111361
   PubMed Web of Science ®Google Scholar
• Xia X, Liu Z, Qin Q, et al. Long-term survival in nonsurgical esophageal cancer patients who received consolidation chemotherapy compared with patients who received concurrent chemoradiotherapy alone: a systematic review and meta-analysis. Front Oncol. 2020;10:604657. doi:10.3389/fonc.2020.60465733489910
   PubMed Web of Science ®Google Scholar
• Kawamoto T, Nihei K, Sasai K, Karasawa K. Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer. Esophagus. 2018;15:256–262. doi:10.1007/s10388-018-0622-z30225742
   PubMed Web of Science ®Google Scholar